Prozkoumejte nejčtenější články a videa na Campus Sanofi
Event two: Helping young people be comfortable in their skins
Recorded on: 14 November 2023
Event two: Older and itchy: The challenges of managing severe atopic dermatitis in the elderly
Recorded on: 25 October 2022
Event one: Managing severe atopic dermatitis from infancy to adolescence: Challenges and insights
Recorded on: 14 June 2022
Event one: Real-World Challenges in Severe Atopic Dermatitis
Recorded at the 2025 ADC Annual Scientific Meeting
En estudios clínicos, Agalsidasa Beta ha demostrado una tasa substancialmente menor de eventos y muertes renales, cardiacas y cerebrovasculares en la población por protocolo vs. población tratada con placebo.
Conozca más de la eficiencia de la Agalsidasa Beta en el siguiente material.